MRNA — Moderna Inc · rev $145.0M

Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..

Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.

Use this MRNA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MRNA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MRNA SEC filings page. Lician reads the product cache first so this HTML stays unique to Moderna Inc even when a live quote feed is slow.

Moderna Inc latest statements (FY2025)

Latest cached year on this hub. Full MRNA income, balance, and cash tables.

  • Revenue$1.94B
  • Net Income-$2.82B
  • Total Assets$12.34B
  • Total Debt$0
  • Free Cash Flow-$2.06B

MRNA recent filings